Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Has announcements × Thoracic × Clear all

Phase

Phase 3 40 Phase 2 16 Phase 1/2 9 Phase 1 3 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Myeloid 2 Lymphoid 2 Thoracic 1 Other solid neoplasm 1 Genitourinary 1 Dermatologic 1 Breast 1

Conditions

Interventions

pembrolizumab 1 Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02784171 2024-12-10

Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma

Canadian Cancer Trials Group

Phase 2/3 Completed

520 enrolled 16 charts 1 FDA

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡